Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

Buzz on the Bullboards: Where volatility meets opportunity

It has been a wild ride for markets on Bay Street and Wall Street this week. Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day. It is reporting season for many companies, and Stockhouse users seem...
Jonathon Brown | February 15, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |

2023, the dawn of the silver boom

By Chen Lin, chenpicks.com This year saw another year of the huge supply-demand deficit in silver, despite heavy investment selling. The most significant demand increase came from solar panels. In 2021, the Silver Institute and Metal Focus group were looking at PV (...
Research | December 14, 2023 |

Retail advertising and AI-driven security solutions company growing rapidly

The location-based technology provider INEO Tech Corp. (TSXV:INEO) started growing its business right here in Canada but has since expanded to 23 states across the United States and even Colombia. The company has managed to combine advertising at storefront entran...
Brieanna McCutcheon | November 16, 2023 |

Buzz on the Bullboards: New energy, heath, and transport opportunities

Canada’s largest financial portal for Canadian small-cap investors is right here at Stockhouse. It is where our Bullboards – your Bullboards – are a leading forum to discuss these Canadian-listed small-cap businesses. Stocks on both sides of the border...
Jonathon Brown | October 19, 2023 |

Buzz on the Bullboards: Old favourites make their return

September is often seen as a “fresh start” for the markets, like a new year on the stock exchange, but this party was met with a serious hangover in the shape of poor performances among sectors that only just recently began to turn around. One ma...
Jonathon Brown | September 14, 2023 |

Charbone Hydrogen is on a green mission

A Canadian green hydrogen group established in North America, Charbone Hydrogen, is on a mission. The Canadian hydrogen group is positioning itself as a major player in the decarbonization of our planet. The group is fully committed to the energy transition and the drive ...
Brieanna McCutcheon | June 8, 2023 |

AMPD Ventures (CSE:AMPD) and the year ahead

Unlocking the next generation of digital content creation and distribution, AMPD Ventures is a Canadian publicly company. Among its portfolio are many subsidiaries, including AMPD Technologies and the Departure Lounge. Joining us today is James Hursthouse, CEO of AMPD...
Brieanna McCutcheon | May 2, 2023 |
1 2 3 4 5 6 7 8 9 10 ...